Palo Alto Investors »

Bicara Therapeutics shares owned by Palo Alto Investors

Quarter-by-quarter ownership of Bicara Therapeutics (BCAX) shares owned by Palo Alto Investors from 13F filings

Historical chart of Palo Alto Investors investment in Bicara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bicara Therapeutics held by Palo Alto Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bicara Therapeutics by Palo Alto Investors

Quarter filed Position value Share count Share price at filing
2026-03-31 $11M 550k 19.89
2025-12-31 $5.0M 299k 16.83

More positions owned by Palo Alto Investors

Insmed Com Par $.01 (INSM)
ACADIA Pharmaceuticals (ACAD)
Ptc Therapeutics I (PTCT)
BioMarin Pharmaceutical (BMRN)
United Therapeutics Corporation (UTHR)
Anaptysbio Inc Common (ANAB)
Mirum Pharmaceuticals (MIRM)
Dyne Therapeutics (DYN)
Biogen Idec (BIIB)
Disc Medicine (IRON)
Iovance Biotherapeutics (IOVA)
Syndax Pharmaceuticals (SNDX)
Annexon (ANNX)
Amicus Therapeutics (FOLD)
Novocure Ord Shs (NVCR)

View all positions for Palo Alto Investors

Top funds holding Bicara Therapeutics

RA Capital Management
Siren
Vestal Point Capital
Deep Track Capital
Henderson Group
T. Rowe Price Investment Management
Red Tree Management
Tpg Gp A
BlackRock
Omega Fund Management
Vanguard Group
FMR
Vanguard Capital Management
Citadel Advisors
Franklin Resources

View all funds holding Bicara Therapeutics